Ovid Therapeutics
OVID
OVID
38 hedge funds and large institutions have $26.6M invested in Ovid Therapeutics in 2019 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
42% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 12
Holders
38
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$668K | |
| 2 | +$486K | |
| 3 | +$420K | |
| 4 |
Renaissance Technologies
New York
|
+$373K |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$257K |
Top Sellers
| 1 | -$4.09M | |
| 2 | -$1.99M | |
| 3 | -$800K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$394K |
| 5 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$225K |